Small Molecules
3 October 2013
Orexigen Therapeutics Submits Contrave Marketing Authorization Application to European Medicines Agency3 October 2013
Highland Therapeutics Announces Positive Interim Results From Phase I/II Study of HLD-200 in ADHD Patients3 October 2013
Aubagio® Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study3 October 2013
EISAI RECEIVES EUROPEAN COMMISSION APPROVAL ON USE OF ANTIEPILEPTIC AGENT ZONEGRAN(R) IN PEDIATRIC PATIENTS1 October 2013
Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder1 October 2013
Ocular Therapeutix Announces Phase 2 Study Results for Sustained Release Dexamethasone30 September 2013
Moleculin Reports Positive Data From Controlled Study of Novel Topical Psoriasis Treatment30 September 2013
Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-31130 September 2013
Data Presented at European Cancer Congress Suggest Clinical Benefit of Tivantinib in Patients with MET High Non-Squamous Non-Small Cell Lung Cancer30 September 2013
Lithera Reports Positive Clinical Study Results From Its Phase 2b RESET Trial for LIPO-202, a Novel Treatment for Abdominal Body Contouring30 September 2013
CytRx’s New Aldoxorubicin Data Demonstrates Significant Advantages over Doxorubicin30 September 2013
TESARO Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 201330 September 2013
BioMarin Provides Updated Phase 1/2 Data on BMN 673 in Breast Cancer at the European Cancer Congress 201330 September 2013
Nintedanib* extended survival beyond one year for advanced adenocarcinoma patients after prior first-line chemotherapy29 September 2013
Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and ScheduleNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports